Events

May 24, 2017
12:00 PM

 

Abstract:

Clinical development of deep brain stimulation (DBS) therapies for treatment-resistant depression (TRD) has suffered numerous set backs over the last 5 years, after a premature rush to evaluate early iterations of the technology in pivotal clinical trials. However, new scientific insights into the underlying neural circuitry dysfunction of depression, coupled with advanced brain imaging tools, are providing an encouraging path forward for the next generation of clinical DBS experiments. This presentation will highlight the imaging foundation, computational tools, and software infrastructure that is giving new hope to the application of DBS technology for the treatment of depression.

About the Speaker:

Cameron McIntyre, PhD, was born in Marietta, OH in 1974. He received his BS and PhD in Biomedical Engineering from Case Western Reserve University in 1997 and 2001, respectively. His doctoral research focused on the biophysics of the interaction between electric fields and neurons. From 2001 to 2003, he performed postdoctoral training at Johns Hopkins University and Emory University where he studied deep brain stimulation (DBS). In 2003 he joined the faculty at the Cleveland Clinic Foundation and maintained a laboratory there until 2012. In 2013, the McIntyre lab moved to Case Western Reserve University to create the Case Neuromodulation Center.